Corindus Vascular Robotics, Inc. (CVRS)
(Delayed Data from AMEX)
$2.17 USD
-0.01 (-0.46%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.19 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.17 USD
-0.01 (-0.46%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.19 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Analysts Estimate Corindus Vascular Robotics (CVRS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corindus Vascular Robotics (CVRS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corindus Vascular (CVRS) delivered earnings and revenue surprises of -20.00% and 11.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Corindus Vascular Robotics (CVRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corindus Vascular Robotics (CVRS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Corindus Vascular (CVRS) delivered earnings and revenue surprises of 0.00% and 4.69%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Corindus Vascular Robotics (CVRS) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Corindus Vascular Robotics (CVRS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corindus Vascular Robotics (CVRS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Corindus Vascular (CVRS) delivered earnings and revenue surprises of 14.29% and -44.50%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Corindus Vascular Robotics (CVRS) Soars: Stock Adds 14.2% in Session
by Zacks Equity Research
Corindus Vascular Robotics (CVRS) saw a big move last session, as its shares jumped more than 14% on the day, amid huge volumes.
Corindus Vascular Robotics (CVRS) Jumps: Stock Gains 19.5%
by Zacks Equity Research
Corindus Vascular Robotics, Inc. (CVRS) move big last session, as its shares rose over 19% on the day.